NATCOPHARMNSEOffline
NATCO PHARMA · INE987B01026 · Small Cap · #389- Prev close
- 788.75
- Open
- —
- High
- —
- Low
- —
- Volume
- —
- Mkt cap (6-mo avg)
- ₹17,418 cr
Loading minute bars…
NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.
NATCOPHARM is 34% below its 52-week high, below its 200-day average, behind Healthcare by 14.0 pts over 3 months — a Small Cap company, #389 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice
Overview
What the data says, line by line
A description, never a buy or sell word · tap a line for its detail
How big is it?
six-month average market cap
Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.
Did buyers take delivery?
latest session · 2026-11-05
Price & trend
Returns
to 05 Nov 2026
| Period | Stock | vs Nifty 500 | vs its industry |
|---|---|---|---|
| 1 week | +1.1% | −4.4 pts | — |
| 1 month | −3.3% | −7.5 pts | −6.9 pts |
| 3 months | −13.2% | −11.3 pts | −14.0 pts |
| 6 months | −30.7% | −31.0 pts | −37.5 pts |
| 1 year | −4.4% | −1.9 pts | — |
Industry: Healthcare (Nifty 500 classification) · rank 40 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.
Averages & movement
Ownership
Who owns the company
% of all shares, by quarter
| Group | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|
| Promoters | 49.5% | 49.4% −0.1 | 49.4% | 49.4% |
| FPI | 15.2% | 17.4% +2.2 | 17.0% −0.4 | 16.0% −1.0 |
| Mutual funds | 1.6% | 1.7% +0.1 | 1.9% +0.2 | 2.3% +0.3 |
| Other DII | 3.8% | 3.7% | 3.7% | 3.9% +0.2 |
| Individuals | 25.4% | 23.3% −2.1 | 23.4% +0.1 | 23.9% +0.4 |
| Others | 4.6% | 4.4% −0.2 | 4.6% +0.1 | 4.6% |
From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.
Promoter pledge
Sep 26
Holders
Sep 26
Indian passive funds’ stake
2026-06-30
9,49,686 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.
Which funds bought and sold
mutual funds · quarter ended 2026-06-30
| Fund | Shares | Change | Did |
|---|---|---|---|
| Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund-Reg(G)Index | +22,257 | +222.1% | bought |
| Bandhan Multi Cap Fund-Reg(G)Active | +1,25,000 | +166.7% | bought |
| Mirae Asset Nifty MidSmallcap400 Momentum Quality 100 ETFIndex | +6,115 | +52.4% | bought |
| JioBlackRock Flexi Cap Fund(G)-Direct PlanActive | −1,65,584 | −79.4% | sold |
| HDFC NIFTY Smallcap 250 ETFIndex | −788 | −0.7% | sold |
| Tata Nifty MidSmall Healthcare Index Fund-Reg(G)Index | −125 | −0.5% | sold |
Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.
Mutual-fund schemes, month by month
fund houses’ own monthly portfolios
| Month | Schemes | Bought new | Added | Cut | Sold out | Shares held | Value |
|---|---|---|---|---|---|---|---|
| Sep 26 | 72 | 6 | 19 | 36 | 5 | +20.4% | ₹300 cr |
| Aug 26 | 71 | 5 | 45 | 10 | 3 | −2.4% | ₹253 cr |
| Jul 26 | 69 | 3 | 32 | 19 | 6 | −2.3% | ₹283 cr |
| Jun 26 | 72 | 7 | 38 | 13 | 1 | −3.3% | ₹294 cr |
| May 26 | 66 | 7 | 25 | 18 | 0 | +9.3% | ₹332 cr |
| Apr 26 | 59 | 2 | 35 | 11 | 0 | −1.5% | ₹327 cr |
Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.
Fund ownership is a quarterly disclosure and counts Indian passive schemes only.
Results
Results
Events & filings
Insider trades
SEBI PIT disclosures filed with NSE
| 26 Oct 2026 | VENKAIAH CHOWDARY NANNAPANENI | Promoter and Director | Buy | 5,86,666 | ₹44 cr | 0.15% | Allotment |
| 26 Oct 2026 | CHEKURI VENKAT RAMESH | KMP | Buy | 114 | ₹85,500 | 0.00% | Allotment |
| 26 Oct 2026 | NITIN JAIN (HUF) | Director | Buy | 3,000 | ₹0.23 cr | 0.00% | Allotment |
| 26 Oct 2026 | SIVARAMAKRISHNA PRASAD POTLURI | Director | Buy | 4,000 | ₹0.3 cr | 0.00% | Allotment |
| 26 Oct 2026 | LINGARAO DONTHINENI | Director | Buy | 5,157 | ₹0.39 cr | 0.00% | Allotment |
| 26 Oct 2026 | KANTAMANI RATNA KUMAR | Promoter Group | Buy | 4,761 | ₹0.36 cr | 0.00% | Allotment |
| 26 Oct 2026 | V S SWATHI KANTAMANI | Promoter Group | Buy | 61,333 | ₹4.6 cr | 0.08% | Allotment |
| 26 Oct 2026 | SAU FAMILY TRUST | Promoter | Buy | 161 | ₹0.01 cr | 0.00% | Allotment |
| 26 Oct 2026 | VISTRA ITCL LIMITED A/C VCN FAMILY TRUST | Promoter | Buy | 161 | ₹0.01 cr | 0.00% | Allotment |
| 26 Oct 2026 | VISTRA ITCL LIMITED A/C NEELIMA TRUST | Promoter | Buy | 69,785 | ₹5.23 cr | 0.02% | Allotment |
| 26 Oct 2026 | NATCO AQUA LIMITED | Promoter Group | Buy | 1,523 | ₹0.11 cr | 0.00% | Allotment |
| 26 Oct 2026 | NATSOFT INFORMATION SYSTEMS PVT LTD | Promoter Group | Buy | 2,40,000 | ₹18 cr | 0.08% | Allotment |
| 26 Oct 2026 | TIME CAP PHAMA LABS PVT LTD | Promoter Group | Buy | 9,33,333 | ₹70 cr | 0.09% | Allotment |
| 26 Oct 2026 | RAJEEV NANNAPANENI | Promoter and Director | Buy | 58,666 | ₹4.4 cr | 0.01% | Allotment |
| 26 Oct 2026 | NEELIMA SITA NANNAPANENI | Promoter | Buy | 2,55,387 | ₹19.15 cr | 0.00% | Allotment |
Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.
Disclosures & deals
last six months · NSE filings
- Scheme / acquisition28 Sept 2026
- Board outcome09 Sept 2026
- Scheme / acquisition25 Aug 2026
- Board outcome14 Aug 2026
- Board outcome14 Aug 2026
- Scheme / acquisition08 Jul 2026
Latest shown; 8 in six months on all disclosures.
NATCOPHARM: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.
Corporate actions
full published history
| Recent | Rights | 2:21 | — | 01 Oct 2026 | 01 Oct 2026 | at ₹750 |
| Recent | Dividend | ₹1.5 | Interim | 20 Aug 2026 | 20 Aug 2026 | |
| Earlier | Dividend | ₹1.5 | Interim | 18 Feb 2026 | 18 Feb 2026 | |
| Earlier | Dividend | ₹1.5 | Interim | 20 Nov 2025 | 20 Nov 2025 | |
| Earlier | Dividend | ₹2 | Interim | 19 Aug 2025 | 19 Aug 2025 | |
| Earlier | Dividend | ₹1.5 | Interim | 18 Feb 2025 | 18 Feb 2025 | |
| Earlier | Dividend | ₹1.5 | Interim | 27 Nov 2024 | 27 Nov 2024 | |
| Earlier | Dividend | ₹3 | Interim | 23 Aug 2024 | 23 Aug 2024 | |
| Earlier | Dividend | ₹1.25 | Interim | 26 Feb 2024 | 26 Feb 2024 | |
| Earlier | Dividend | ₹1.25 | Interim | 24 Nov 2023 | 24 Nov 2023 |
16 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.
Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.